Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences, Inc.
Daniel O'Day serves as Chairman of the Board of Directors and Chief Executive Officer at Gilead Sciences.
Dan joined Gilead in March 2019 after more than three decades at Roche Pharmaceuticals where he also served as Chief Executive Officer. During his career at Roche, he held a number of prior executive positions in the company's pharmaceutical and diagnostics divisions in North America, Europe and Asia. He was a member of Roche's Corporate Executive Committee and served on several public and private boards, including Genentech, Flatiron Health and Foundation Medicine.
Dan holds a bachelor's degree in biology from Georgetown University and an MBA from Columbia University in New York. He currently serves on the board of directors for the Pharmaceutical Research and Manufacturers of America organization, Galapagos NV and Georgetown University.
-
Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences, Inc.
-
Andrew Dickinson
Chief Financial Officer
-
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
-
Flavius Martin
Executive Vice President, Research
-
Jyoti Mehra
Executive Vice President, Human Resources
-
Johanna Mercier
Chief Commercial Officer
-
Merdad Parsey, MD, PhD
Chief Medical Officer
-
Cindy Perettie
Executive Vice President, Kite
-
Deborah H. Telman
Executive Vice President, Corporate Affairs and General Counsel